Strengthening the Shipping of Biological Specimens for Rapid Disease Detection and Response Since 2016, the WHO Global Influenza Program (GIP) has been supporting the United Nations Food and Agriculture Organization (FAO) in conducting regular infectious substances shipment training (ISST) as…
Influenza Virus Sharing Essential for Pandemic Preparedness: Yemen Achieves Milestone with WHO Collaboration Virus sharing is crucial for global pandemic preparedness, enabling the development of vaccine candidates, monitoring antiviral resistance, and updating diagnostic tools. Due to ongoing conflict, Yemen has…
Elanco’s Parvovirus Antibody Treatment Saves Thousands of Puppies in First Year Elanco Animal Health has released the first real-world data showcasing the effectiveness of its Canine Parvovirus Monoclonal Antibody (CPMA), the first USDA Conditionally Approved targeted treatment for canine parvovirus.…
As part of a three-year, $30 million initiative focused on mental health and well-being, the Anthem Blue Cross and Blue Shield Foundation has launched a new program in Shenandoah County, Virginia, to tackle the substance use disorder (SUD) crisis affecting…
FDA Approves Optune Lua® as First-of-its-Kind Treatment for Metastatic Non-Small Cell Lung Cancer Novocure (NASDAQ: NVCR) announced that the U.S. Food and Drug Administration (FDA) has approved Optune Lua®, a groundbreaking treatment for metastatic non-small cell lung cancer (mNSCLC). The…
Supergut, the first clinically validated nutrition brand for gut health, is now available at Target stores across the U.S. and online at Target.com. The brand’s exclusive Target lineup features its range of prebiotic superfoods, including award-winning Bars, all-in-one Shakes, and…
Veterinary technicians play a vital role in the veterinary field, carrying out important tasks such as assisting in surgeries, conducting diagnostic tests, and providing emergency care. To meet the increasing demand for animal care and adapt to the changing needs…
Gilead Sciences, Inc. has announced the presentation of new findings from its antiviral research and development programs at IDWeek 2024, scheduled for October 16-19. The presentations will include data from 31 studies focused on HIV treatment and prevention, COVID-19, and…
AstraZeneca’s Airsupra (albuterol/budesonide) has demonstrated promising outcomes in the BATURA Phase IIIb trial, achieving its primary endpoint by significantly and meaningfully reducing the risk of severe asthma exacerbations when used as an as-needed rescue medication compared to albuterol alone. This…
Roche (SIX: RO, ROG; OTCQX: RHHBY) presented promising two-year findings from the ongoing RAINBOWFISH study at the 29th World Muscle Society (WMS) Congress, held from October 8-12, 2024. The study evaluates the efficacy and safety of Evrysdi® (risdiplam) in infants…
Merck (NYSE: MRK), also known as MSD outside the U.S. and Canada, announced today that its Phase 3 KEYNOTE-689 trial met the primary endpoint of event-free survival (EFS) for KEYTRUDA® (pembrolizumab). This trial focused on using KEYTRUDA, Merck’s anti-PD-1 therapy,…
The AIDS Healthcare Foundation (AHF) has expressed support for Gilead’s recent decision to expand the availability of lenacapavir, a long-acting HIV treatment, to 120 countries through voluntary licensing agreements with six generic manufacturers. However, AHF emphasizes that key countries affected…
